Evidence map›Paper›PMID 29181079›Full record

ArticleArchives of medical science : AMS2017

Survivin expression, HPV positivity and microvessel density in oropharyngeal carcinomas and relationship with survival time.

Ebru Tastekin, Vuslat Yurut Caloglu, Nilufer Kilic Durankus, Necdet Sut, Gorkem Turkkan, Nuray Can, Fulya Oz Puyan, Murat Caloglu

Open access · goldAbstract read
In one paragraph

Article in Archives of medical science : AMS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ebru TastekinDepartment of Pathology, Medical Faculty, Trakya University, Edirne, Turkey.
Vuslat Yurut CalogluDepartment of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Nilufer Kilic DurankusDepartment of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Necdet SutDepartment of Biostatistics, Faculty of Medicine, Trakya University, Edirne, Turkey.
Gorkem TurkkanDepartment of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Nuray CanDepartment of Pathology, Medical Faculty, Trakya University, Edirne, Turkey.
Fulya Oz PuyanDepartment of Pathology, Medical Faculty, Trakya University, Edirne, Turkey.
Murat CalogluDepartment of Radiation Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Trakya University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAmong head and neck cancers, those of the oral cavity and oropharynx are the second most prevalent following the larynx. This study aimed to research immunohistochemical expression of survivin, HPV positivity and microvessel density in tumors and their relationships with prognosis. MATERIAL AND

methodsPathological materials and demographic properties of 46 patients were retrospectively evaluated. Survivin, HPV and CD34 (for microvessel density evaluation) antibodies were applied tumoral tissues. Survival times, clinical stage and differentiation were evaluated.

resultsIn univariate analysis, we observed that survivin, microvessel density and stage were significantly associated with survival time (

conclusionsSurvivin levels and microvessel density were found to be effective prognostic factors and were related to survival in oral cavity and oropharyngeal cancers. Treatments targeting survivin expression and angiogenesis might be employed against these tumor groups.

Indexed as

oral cavity tumorsoropharyngeal carcinomaprognosissurvivin

Identifiers

PMID29181079
PMCPMC5701673
OpenAlexW2404667750

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.